Global Drug Repurposing Market Research Report 2025(Status and Outlook)

March 2025 | 197 pages | ID: G50984F2AB6DEN
Bosson Research

Abstracts

Report Overview

Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive drug development process. Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by saving time and money while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for anti-cancer activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies. However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for breast cancer treatment), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.

This report provides a deep insight into the global Drug Repurposing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug Repurposing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug Repurposing market in any manner.

Global Drug Repurposing Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Astellas Pharma

Biovista

Novartis

AbbVie

Pfizer

Allergan

NuMedii

Market Segmentation (by Type)

Oncology

CNS Diseases

Neurodegenerative Diseases

Others

Market Segmentation (by Application)

Hospitals

Ambulatory Surgical Centers

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Drug Repurposing Market
• Overview of the regional outlook of the Drug Repurposing Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Repurposing Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Drug Repurposing
1.2 Key Market Segments
1.2.1 Drug Repurposing Segment by Type
1.2.2 Drug Repurposing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Drug Repurposing Market Overview
2.1 Global Market Overview
2.1.1 Global Drug Repurposing Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Drug Repurposing Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Drug Repurposing Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Drug Repurposing Product Life Cycle
3.3 Global Drug Repurposing Sales by Manufacturers (2020-2025)
3.4 Global Drug Repurposing Revenue Market Share by Manufacturers (2020-2025)
3.5 Drug Repurposing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Drug Repurposing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Drug Repurposing Manufacturing Sites, Area Served, Product Type
3.8 Drug Repurposing Market Competitive Situation and Trends
3.8.1 Drug Repurposing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Drug Repurposing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Drug Repurposing Industry Chain Analysis
4.1 Drug Repurposing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Drug Repurposing Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Drug Repurposing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Drug Repurposing Market
5.7 ESG Ratings of Leading Companies
6 Global Drug Repurposing Market by Region
6.1 Global Drug Repurposing Market Size by Region
6.1.1 Global Drug Repurposing Market Size by Region
6.1.2 Global Drug Repurposing Market Size Market Share by Region
6.2 Global Drug Repurposing Sales by Region
6.2.1 Global Drug Repurposing Sales by Region
6.2.2 Global Drug Repurposing Sales Market Share by Region
7 North America Market Overview
7.1 North America Drug Repurposing Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Drug Repurposing Market Size by Type
7.3 North America Drug Repurposing Market Size by Application
8 Europe Market Overview
8.1 Europe Drug Repurposing Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Drug Repurposing Market Size by Type
8.3 Europe Drug Repurposing Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Drug Repurposing Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Drug Repurposing Market Size by Type
9.3 Asia-Pacific Drug Repurposing Market Size by Application
10 South America Market Overview
10.1 South America Drug Repurposing Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Drug Repurposing Market Size by Type
10.3 South America Drug Repurposing Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Drug Repurposing Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Drug Repurposing Market Size by Type
11.3 Middle East and Africa Drug Repurposing Market Size by Application
12 Drug Repurposing Market Production by Region
12.1 Global Production of Drug Repurposing by Region(2020-2025)
12.2 Global Drug Repurposing Revenue Market Share by Region (2020-2025)
12.3 Global Drug Repurposing Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Drug Repurposing Production
12.4.1 North America Drug Repurposing Production Growth Rate (2020-2025)
12.4.2 North America Drug Repurposing Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Drug Repurposing Production
12.5.1 Europe Drug Repurposing Production Growth Rate (2020-2025)
12.5.2 Europe Drug Repurposing Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Drug Repurposing Production (2020-2025)
12.6.1 Japan Drug Repurposing Production Growth Rate (2020-2025)
12.6.2 Japan Drug Repurposing Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Drug Repurposing Production (2020-2025)
12.7.1 China Drug Repurposing Production Growth Rate (2020-2025)
12.7.2 China Drug Repurposing Production, Revenue, Price and Gross Margin (2020-2025)
13 Drug Repurposing Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Drug Repurposing Sales Market Share by Type (2020-2033)
13.3 Global Drug Repurposing Market Size Market Share by Type (2020-2033)
13.4 Global Drug Repurposing Price by Type (2020-2033)
14 Drug Repurposing Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Drug Repurposing Market Sales by Application (2020-2033)
14.3 Global Drug Repurposing Market Size (M USD) by Application (2020-2033)
14.4 Global Drug Repurposing Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Astellas Pharma
15.1.1 Astellas Pharma Basic Information
15.1.2 Astellas Pharma Drug Repurposing Product Overview
15.1.3 Astellas Pharma Drug Repurposing Product Market Performance
15.1.4 Astellas Pharma Business Overview
15.1.5 Astellas Pharma SWOT Analysis
15.1.6 Astellas Pharma Recent Developments
15.2 Biovista
15.2.1 Biovista Basic Information
15.2.2 Biovista Drug Repurposing Product Overview
15.2.3 Biovista Drug Repurposing Product Market Performance
15.2.4 Biovista Business Overview
15.2.5 Biovista SWOT Analysis
15.2.6 Biovista Recent Developments
15.3 Novartis
15.3.1 Novartis Basic Information
15.3.2 Novartis Drug Repurposing Product Overview
15.3.3 Novartis Drug Repurposing Product Market Performance
15.3.4 Novartis Business Overview
15.3.5 Novartis SWOT Analysis
15.3.6 Novartis Recent Developments
15.4 AbbVie
15.4.1 AbbVie Basic Information
15.4.2 AbbVie Drug Repurposing Product Overview
15.4.3 AbbVie Drug Repurposing Product Market Performance
15.4.4 AbbVie Business Overview
15.4.5 AbbVie Recent Developments
15.5 Pfizer
15.5.1 Pfizer Basic Information
15.5.2 Pfizer Drug Repurposing Product Overview
15.5.3 Pfizer Drug Repurposing Product Market Performance
15.5.4 Pfizer Business Overview
15.5.5 Pfizer Recent Developments
15.6 Allergan
15.6.1 Allergan Basic Information
15.6.2 Allergan Drug Repurposing Product Overview
15.6.3 Allergan Drug Repurposing Product Market Performance
15.6.4 Allergan Business Overview
15.6.5 Allergan Recent Developments
15.7 NuMedii
15.7.1 NuMedii Basic Information
15.7.2 NuMedii Drug Repurposing Product Overview
15.7.3 NuMedii Drug Repurposing Product Market Performance
15.7.4 NuMedii Business Overview
15.7.5 NuMedii Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Drug Repurposing Market Size by Type (M USD)
Table 4. Global Drug Repurposing Market Size by Application (M USD)
Table 5. Drug Repurposing Market Size Comparison by Region (M USD)
Table 6. Global Drug Repurposing Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Drug Repurposing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Drug Repurposing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Drug Repurposing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repurposing as of 2024)
Table 11. Global Market Drug Repurposing Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Drug Repurposing Manufacturing Sites and Area Served
Table 13. Manufacturers Drug Repurposing Product Type
Table 14. Global Drug Repurposing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Drug Repurposing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Drug Repurposing Market Size Comparison by Region (M USD)
Table 26. Global Drug Repurposing Market Size by Region (2020-2033) & (M USD)
Table 27. Global Drug Repurposing Market Size Market Share by Region (2020-2033)
Table 28. Global Drug Repurposing Sales by Region (2020-2033) & (K MT)
Table 29. Global Drug Repurposing Sales Market Share by Region (2020-2033)
Table 30. North America Drug Repurposing Market Size by Country (2020-2033) & (M USD)
Table 31. North America Drug Repurposing Sales by Country (2020-2033) & (K MT)
Table 32. North America Drug Repurposing Sales by Type (K MT)
Table 33. North America Drug Repurposing Market Size by Type (M USD)
Table 34. North America Drug Repurposing Sales (K MT) by Type (2020-2033)
Table 35. North America Drug Repurposing Market Size (M USD) by Type (2020-2033)
Table 36. North America Drug Repurposing Sales by Application (K MT)
Table 37. North America Drug Repurposing Market Size by Application (M USD)
Table 38. North America Drug Repurposing Sales (K MT) by Application (2020-2033)
Table 39. North America Drug Repurposing Market Size (M USD) by Application (2020-2033)
Table 40. Europe Drug Repurposing Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Drug Repurposing Sales by Country (2020-2033) & (K MT)
Table 42. Europe Drug Repurposing Sales by Type (K MT)
Table 43. Europe Drug Repurposing Market Size by Type (M USD)
Table 44. Europe Drug Repurposing Sales (K MT) by Type (2020-2033)
Table 45. Europe Drug Repurposing Market Size (M USD) by Type (2020-2033)
Table 46. Europe Drug Repurposing Sales by Application (K MT)
Table 47. Europe Drug Repurposing Market Size by Application (M USD)
Table 48. Europe Drug Repurposing Sales (K MT) by Application (2020-2033)
Table 49. Europe Drug Repurposing Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Drug Repurposing Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Drug Repurposing Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Drug Repurposing Sales by Type (K MT)
Table 53. Asia-Pacific Drug Repurposing Market Size by Type (M USD)
Table 54. Asia-Pacific Drug Repurposing Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Drug Repurposing Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Drug Repurposing Sales by Application (K MT)
Table 57. Asia-Pacific Drug Repurposing Market Size by Application (M USD)
Table 58. Asia-Pacific Drug Repurposing Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Drug Repurposing Market Size (M USD) by Application (2020-2025)
Table 60. South America Drug Repurposing Market Size by Country (2020-2033) & (M USD)
Table 61. South America Drug Repurposing Sales by Country (2020-2033) & (K MT)
Table 62. South America Drug Repurposing Sales by Type (K MT)
Table 63. South America Drug Repurposing Market Size by Type (M USD)
Table 64. South America Drug Repurposing Sales (K MT) by Type (2020-2033)
Table 65. South America Drug Repurposing Market Size (M USD) by Type (2020-2033)
Table 66. South America Drug Repurposing Sales by Application (K MT)
Table 67. South America Drug Repurposing Market Size by Application (M USD)
Table 68. South America Drug Repurposing Sales (K MT) by Application (2020-2033)
Table 69. South America Drug Repurposing Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Drug Repurposing Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Drug Repurposing Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Drug Repurposing Sales by Type (K MT)
Table 73. Middle East and Africa Drug Repurposing Market Size by Type (M USD)
Table 74. Middle East and Africa Drug Repurposing Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Drug Repurposing Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Drug Repurposing Sales by Application (K MT)
Table 77. Middle East and Africa Drug Repurposing Market Size by Application (M USD)
Table 78. Middle East and Africa Drug Repurposing Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Drug Repurposing Market Size (M USD) by Application (2020-2033)
Table 80. Global Drug Repurposing Production (K MT) by Region(2020-2025)
Table 81. Global Drug Repurposing Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Drug Repurposing Revenue Market Share by Region (2020-2025)
Table 83. Global Drug Repurposing Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Drug Repurposing Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Drug Repurposing Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Drug Repurposing Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Drug Repurposing Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Drug Repurposing Sales by Type (K MT)
Table 89. Global Drug Repurposing Market Size by Type (M USD)
Table 90. Global Drug Repurposing Sales (K MT) by Type (2020-2033)
Table 91. Global Drug Repurposing Sales Market Share by Type (2020-2033)
Table 92. Global Drug Repurposing Market Size (M USD) by Type (2020-2033)
Table 93. Global Drug Repurposing Market Size Share by Type (2020-2033)
Table 94. Global Drug Repurposing Sales (K MT) by Application
Table 95. Global Drug Repurposing Market Size by Application(M USD)
Table 96. Global Drug Repurposing Sales by Application (2020-2033) & (K MT)
Table 97. Global Drug Repurposing Sales Market Share by Application (2020-2033)
Table 98. Global Drug Repurposing Market Size by Application (2020-2033) & (M USD)
Table 99. Global Drug Repurposing Market Share by Application (2020-2033)
Table 100. Global Drug Repurposing Sales Growth Rate by Application (2020-2033)
Table 101. Astellas Pharma Basic Information
Table 102. Astellas Pharma Drug Repurposing Product Overview
Table 103. Astellas Pharma Drug Repurposing Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Astellas Pharma Business Overview
Table 105. Astellas Pharma SWOT Analysis
Table 106. Astellas Pharma Recent Developments
Table 107. Biovista Basic Information
Table 108. Biovista Drug Repurposing Product Overview
Table 109. Biovista Drug Repurposing Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Biovista Business Overview
Table 111. Biovista SWOT Analysis
Table 112. Biovista Recent Developments
Table 113. Novartis Basic Information
Table 114. Novartis Drug Repurposing Product Overview
Table 115. Novartis Drug Repurposing Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Novartis Business Overview
Table 117. Novartis SWOT Analysis
Table 118. Novartis Recent Developments
Table 119. AbbVie Basic Information
Table 120. AbbVie Drug Repurposing Product Overview
Table 121. AbbVie Drug Repurposing Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. AbbVie Business Overview
Table 123. AbbVie Recent Developments
Table 124. Pfizer Basic Information
Table 125. Pfizer Drug Repurposing Product Overview
Table 126. Pfizer Drug Repurposing Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Pfizer Business Overview
Table 128. Pfizer Recent Developments
Table 129. Allergan Basic Information
Table 130. Allergan Drug Repurposing Product Overview
Table 131. Allergan Drug Repurposing Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Allergan Business Overview
Table 133. Allergan Recent Developments
Table 134. NuMedii Basic Information
Table 135. NuMedii Drug Repurposing Product Overview
Table 136. NuMedii Drug Repurposing Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. NuMedii Business Overview
Table 138. NuMedii Recent Developments
List of Figures
Figure 1. Product Picture of Drug Repurposing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug Repurposing Market Size (M USD), 2024-2033
Figure 5. Global Drug Repurposing Market Size (M USD) (2020-2033)
Figure 6. Global Drug Repurposing Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Drug Repurposing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Drug Repurposing Product Life Cycle
Figure 13. Drug Repurposing Sales Share by Manufacturers in 2024
Figure 14. Global Drug Repurposing Revenue Share by Manufacturers in 2024
Figure 15. Drug Repurposing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Drug Repurposing Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Drug Repurposing Revenue in 2024
Figure 18. Industry Chain Map of Drug Repurposing
Figure 19. Global Drug Repurposing Market PEST Analysis
Figure 20. Global Drug Repurposing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Drug Repurposing Market Size by Region
Figure 27. Global Drug Repurposing Market Size Market Share by Region (2020-2033)
Figure 28. Global Drug Repurposing Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Drug Repurposing Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Drug Repurposing Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Drug Repurposing Market Size (M USD) by Country
Figure 33. USA Drug Repurposing Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Drug Repurposing Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Drug Repurposing Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Drug Repurposing Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Drug Repurposing Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Drug Repurposing Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Drug Repurposing Market Size (M USD)by Type
Figure 40. North America Drug Repurposing Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Drug Repurposing Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Drug Repurposing Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Drug Repurposing Market Size (M USD) by Country
Figure 45. Germany Drug Repurposing Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Drug Repurposing Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Drug Repurposing Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Drug Repurposing Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Drug Repurposing Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Drug Repurposing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Drug Repurposing Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Drug Repurposing Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Drug Repurposing Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Drug Repurposing Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Drug Repurposing Market Size (M USD) by Type
Figure 56. Europe Drug Repurposing Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Drug Repurposing Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Drug Repurposing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Drug Repurposing Market Size (M USD) by Country
Figure 61. China Drug Repurposing Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Drug Repurposing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Drug Repurposing Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Drug Repurposing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Drug Repurposing Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Drug Repurposing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Drug Repurposing Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Drug Repurposing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Drug Repurposing Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Drug Repurposing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Drug Repurposing Market Size (M USD) by Type
Figure 72. Asia-Pacific Drug Repurposing Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Drug Repurposing Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Drug Repurposing Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Drug Repurposing Market Size (M USD) by Country
Figure 77. Brazil Drug Repurposing Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Drug Repurposing Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Drug Repurposing Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Drug Repurposing Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Drug Repurposing Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Drug Repurposing Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Drug Repurposing Market Size (M USD) by Type
Figure 84. South America Drug Repurposing Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Drug Repurposing Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Drug Repurposing Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Drug Repurposing Market Size (M USD) by Country
Figure 89. Saudi Arabia Drug Repurposing Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Drug Repurposing Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Drug Repurposing Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Drug Repurposing Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Drug Repurposing Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Drug Repurposing Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Drug Repurposing Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Drug Repurposing Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Drug Repurposing Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Drug Repurposing Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Drug Repurposing Market Size (M USD) by Type
Figure 100. Middle East and Africa Drug Repurposing Market Size (M USD) by Application
Figure 101. Global Drug Repurposing Production Market Share by Region (2020-2025)
Figure 102. North America Drug Repurposing Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Drug Repurposing Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Drug Repurposing Production (K MT) Growth Rate (2020-2025)
Figure 105. China Drug Repurposing Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Drug Repurposing Market Size by Type (M USD)
Figure 108. Sales Market Share of Drug Repurposing by Type (2020-2033)
Figure 109. Sales Market Share of Drug Repurposing by Type in 2024
Figure 110. Market Size Share of Drug Repurposing by Type (2020-2033)
Figure 111. Market Size Share of Drug Repurposing by Type in 2024
Figure 112. Global Drug Repurposing Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Drug Repurposing Market Size by Application(M USD)
Figure 115. Global Drug Repurposing Market Share by Application
Figure 116. Global Drug Repurposing Sales Market Share by Application (2020-2033)
Figure 117. Global Drug Repurposing Sales Market Share by Application in 2024
Figure 118. Global Drug Repurposing Market Share by Application (2020-2033)
Figure 119. Global Drug Repurposing Market Share by Application in 2024
Figure 120. Global Drug Repurposing Sales Growth Rate by Application (2020-2033)